The ACR’s Basic Research Conference and Clinical Research Conference on October 25–26 to feature new perspectives on development of rheumatoid arthritis, lupus, and vasulitis, and review current thinking on preclinical rheumatic disease
EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis
Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention
Rheumatology Drug Research Should Focus on Particular Groups of Patients
An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment
California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
Advances in Genomics, Bioinformatics Draw New Insights From the Human Genome
Widely held belief that large segments of the human genome consist of ‘junk DNA’ is incorrect, say scientists
Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease
Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders
2013 ACR/ARHP Annual Meeting Scientific Program Preview
Program lineup features courses, sessions of interest to practicing clinicians, and basic and clinical investigators
Rheumatology Research Foundation Funds Study In Juvenile Arthritis
A Foundation grant is helping investigators develop tools to measure and describe disease activity in juvenile arthritis patients
ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome
Research has led to greater understanding of the disease, potential for better treatment options
ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise
Toxicity and appropriate targeting are challenges for small molecule researchers
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- …
- 77
- Next Page »